D. A. Cooper

413 total citations
8 papers, 240 citations indexed

About

D. A. Cooper is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, D. A. Cooper has authored 8 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Oncology. Recurrent topics in D. A. Cooper's work include HIV Research and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Viral-associated cancers and disorders (3 papers). D. A. Cooper is often cited by papers focused on HIV Research and Treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Viral-associated cancers and disorders (3 papers). D. A. Cooper collaborates with scholars based in Australia, United Kingdom and United States. D. A. Cooper's co-authors include Katherine A. Fitzgerald, Rebecca E. Hussey, Stuart F. Schlossman, Gilbert R. Kaufmann, John Zaunders, Ellis L. Reinherz, Stefan Meuer, James C. Hodgdon, Andrew E. Grulich and Neil Bodsworth and has published in prestigious journals such as Blood, The Journal of Immunology and American Journal of Epidemiology.

In The Last Decade

D. A. Cooper

8 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. A. Cooper Australia 6 130 84 79 72 59 8 240
Kathryn M. Zunich United States 7 87 0.7× 255 3.0× 111 1.4× 58 0.8× 51 0.9× 8 395
Jean-Marie Chennebault France 9 122 0.9× 98 1.2× 74 0.9× 24 0.3× 37 0.6× 19 247
Andrew Loughry United Kingdom 6 67 0.5× 106 1.3× 27 0.3× 13 0.2× 176 3.0× 6 320
Barbara Schock United States 8 177 1.4× 82 1.0× 216 2.7× 25 0.3× 105 1.8× 9 318
Alessandra Fantauzzi Italy 11 128 1.0× 68 0.8× 113 1.4× 21 0.3× 47 0.8× 25 265
Naheed Mir United Kingdom 5 57 0.4× 18 0.2× 33 0.4× 28 0.4× 72 1.2× 9 178
Shahzma Merani United States 7 70 0.5× 142 1.7× 58 0.7× 24 0.3× 156 2.6× 9 345
Jette Victor Denmark 7 90 0.7× 99 1.2× 285 3.6× 17 0.2× 257 4.4× 8 397
Richard Kwan United States 6 75 0.6× 96 1.1× 171 2.2× 12 0.2× 180 3.1× 7 311

Countries citing papers authored by D. A. Cooper

Since Specialization
Citations

This map shows the geographic impact of D. A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Cooper more than expected).

Fields of papers citing papers by D. A. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Cooper. The network helps show where D. A. Cooper may publish in the future.

Co-authorship network of co-authors of D. A. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Cooper. A scholar is included among the top collaborators of D. A. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Cooper. D. A. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dickinson, Laura, Janaki Amin, Laura Else, et al.. (2015). Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Clinical Pharmacology & Therapeutics. 98(4). 406–416. 59 indexed citations
2.
Carey, Cara Donahue, Enmoore Lin, Deborah Wentworth, et al.. (2010). Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). HIV Medicine. 12(4). 219–227. 5 indexed citations
3.
Vanhems, Philippe, C. Dassa, John S. Lambert, et al.. (1999). Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection.. PubMed. 21(2). 99–106. 30 indexed citations
4.
Kaufmann, Gilbert R., John Zaunders, & D. A. Cooper. (1999). Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy. Sexually Transmitted Infections. 75(4). 218–224. 28 indexed citations
5.
Grulich, Andrew E., et al.. (1997). Risk of Kaposi's Sarcoma and Oroanal Sexual Contact. American Journal of Epidemiology. 145(8). 673–679. 29 indexed citations
6.
Kaldor, JM, B. Tindall, Phillip Williamson, Jonathan Elford, & D. A. Cooper. (1993). Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men.. PubMed. 6(10). 1145–9. 21 indexed citations
7.
Boyle, Michelle J., William A. Sewell, Ann Apolloni, et al.. (1991). Subtypes of Epstein-Barr virus in human immunodeficiency virus- associated non-Hodgkin lymphoma. Blood. 78(11). 3004–3011. 4 indexed citations
8.
Meuer, Stefan, James C. Hodgdon, D. A. Cooper, et al.. (1983). Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins.. The Journal of Immunology. 131(1). 186–190. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026